powerful

A unique collection of 1639 compounds from food as medicine for high throughput and high content screening;

A unique collection of 1812 natural products with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 4735 pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can be used for high throughput screen

A collection of 1321 TCM monomers with anti-inflammatory activity or targeting molecular therapeutic targets in inflammation, a powerful tool for drug discovery and mechanism study;

A unique collection of 246 fragment-like small molecules for FBDD;

A unique collection of 2703 natural product monomers that meet the Lipinski's Rule of Five , a powerful tool for HTS and HCS screening;

Well-chosen quantity: only contains 989 bioactive compounds after careful selection

A unique collection of 653 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS).

A unique collection of 2928 compounds (TCM monomers) sourcing from traditional Chinese Medicines, is a powerful tool for drug discovery and research in mechanism;

A unique collection of 1230 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening;

A unique collection of 16708 pure natural products with diverse structures and sources covering various plant, animal, and microbe species;

A unique collection of 2270 natural products included in Chinese Pharmacopoeia (CP), a powerful tool for drug development and pharmacological study;

A unique collection of 1147 monomers from 60 TCM plants, a powerful tool for anti-COVID-19 drug discovery, can be used for HTS and HCS screening;

122 tumor-targeted drugs that can be used for high-throughput and high-content screening.

1196 glycometabolism-related comounds, can be used for HTS and HCT;

A unique collection of 779 ferroptosis signaling pathway related compounds, a powerful tool for new target identification, drug discovery, and mechanism study;

97 Chemotherapeutic drugs that can be used for high-throughput and high-content screening.

A unique collection of 1106 antibacterial bioactive compounds, a powerful tool for antibacterial drug development;

210 macrocyclic compounds of known activity for high-throughput, high-content screening;

A unique collection of 263 kinase inhibitors regulators for specific targeting of kinases, ready for high-throughput screening and high-content screening.

Detialed biological information and pharmacological information of the products, providing theoretical direction and research basis for screening.

1119 drug fragments,a must-have tool for FBDD;

A unique collection of 693 rare natural products, which can be used for high throughput screening (HTS) and high content screening (HCS);

678 hypertension-related small molecules for high-throughput and high-content screening.